Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Megna

Showing results (21-30 of 381) with videos related to

Pageof 39
Sort By:
Psoriasis (Auckland, N.Z.)|July 21, 2022
Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective StudyMatteo Megna, Luca Potestio, Gabriella Fabbrocini, et al.
The Journal of Dermatological Treatment|August 7, 2018
Letter to the editor submitted in response to "psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab"Matteo Megna, Alessia Villani, Nicola Balato, et al.
Tropical Medicine and Infectious Disease|February 24, 2023
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Italian Journal of Dermatology and Venereology|April 29, 2021
Ultraviolet radiation, vitamin D, and COVID-19Matteo Megna, Claudio Marasca, Gabriella Fabbrocini, et al.
Dermatology Practical & Conceptual|May 6, 2021
Is It Possible to Improve Scabies Diagnosis Performance?Vincenzo Greco, Massimiliano Scalvenzi, Gabriella Fabbrocini, et al.
Drugs in Context|June 29, 2026
Deucravacitinib in dermatology: current indication and existing off-label dataMichela D'Agostino, Luca Potestio, Nello Tommasino, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 20, 2024
Reply to 'Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa' by Holgersen et alFabrizio Martora, Teresa Battista, Luca Potestio, et al.
Clinical and Experimental Dermatology|June 3, 2022
Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concernsAngelo Ruggiero, Matteo Megna, Gabriella Fabbrocini, et al.
Expert Opinion on Biological Therapy|June 13, 2022
Treating psoriasis in the elderly: biologics and small moleculesMatteo Megna, Luca Potestio, Gabriella Fabbrocini, et al.
Dermatologic Therapy|March 29, 2020
A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilarMatteo Megna, Gabriella Fabbrocini, Claudia Costa, et al.
Pageof 39

Showing results (21-30 of 381) with videos related to

Sort By:
Pageof 39
Psoriasis (Auckland, N.Z.)|July 21, 2022
Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective StudyMatteo Megna, Luca Potestio, Gabriella Fabbrocini, et al.
The Journal of Dermatological Treatment|August 7, 2018
Letter to the editor submitted in response to "psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab"Matteo Megna, Alessia Villani, Nicola Balato, et al.
Tropical Medicine and Infectious Disease|February 24, 2023
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Italian Journal of Dermatology and Venereology|April 29, 2021
Ultraviolet radiation, vitamin D, and COVID-19Matteo Megna, Claudio Marasca, Gabriella Fabbrocini, et al.
Dermatology Practical & Conceptual|May 6, 2021
Is It Possible to Improve Scabies Diagnosis Performance?Vincenzo Greco, Massimiliano Scalvenzi, Gabriella Fabbrocini, et al.
Drugs in Context|June 29, 2026
Deucravacitinib in dermatology: current indication and existing off-label dataMichela D'Agostino, Luca Potestio, Nello Tommasino, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 20, 2024
Reply to 'Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa' by Holgersen et alFabrizio Martora, Teresa Battista, Luca Potestio, et al.
Clinical and Experimental Dermatology|June 3, 2022
Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concernsAngelo Ruggiero, Matteo Megna, Gabriella Fabbrocini, et al.
Expert Opinion on Biological Therapy|June 13, 2022
Treating psoriasis in the elderly: biologics and small moleculesMatteo Megna, Luca Potestio, Gabriella Fabbrocini, et al.
Dermatologic Therapy|March 29, 2020
A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilarMatteo Megna, Gabriella Fabbrocini, Claudia Costa, et al.
Pageof 39